221 related articles for article (PubMed ID: 27452419)
1. Mechanisms of imiquimod skin penetration.
Telò I; Pescina S; Padula C; Santi P; Nicoli S
Int J Pharm; 2016 Sep; 511(1):516-523. PubMed ID: 27452419
[TBL] [Abstract][Full Text] [Related]
2. Microemulsions based on TPGS and isostearic acid for imiquimod formulation and skin delivery.
Pescina S; Garrastazu G; Del Favero E; Rondelli V; Cantù L; Padula C; Santi P; Nicoli S
Eur J Pharm Sci; 2018 Dec; 125():223-231. PubMed ID: 30316975
[TBL] [Abstract][Full Text] [Related]
3. Gel-like TPGS-Based Microemulsions for Imiquimod Dermal Delivery: Role of Mesostructure on the Uptake and Distribution into the Skin.
Telò I; Favero ED; Cantù L; Frattini N; Pescina S; Padula C; Santi P; Sonvico F; Nicoli S
Mol Pharm; 2017 Oct; 14(10):3281-3289. PubMed ID: 28825487
[TBL] [Abstract][Full Text] [Related]
4. Phospholipid-Based Microemulsions for Cutaneous Imiquimod Delivery.
Panoutsopoulou E; Zbytovská J; Vávrová K; Paraskevopoulos G
Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631342
[TBL] [Abstract][Full Text] [Related]
5. Maximum transepidermal flux for similar size phenolic compounds is enhanced by solvent uptake into the skin.
Zhang Q; Li P; Roberts MS
J Control Release; 2011 Aug; 154(1):50-7. PubMed ID: 21549777
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimod.
Lapteva M; Mignot M; Mondon K; Möller M; Gurny R; Kalia YN
Eur J Pharm Biopharm; 2019 Sep; 142():553-562. PubMed ID: 30641138
[TBL] [Abstract][Full Text] [Related]
7. Effect of the solvent system on the in vitro permeability of nicardipine hydrochloride through excised rat epidermis.
Krishnaiah YS; Satyanarayana V; Karthikeyan RS
J Pharm Pharm Sci; 2002; 5(2):123-30. PubMed ID: 12207864
[TBL] [Abstract][Full Text] [Related]
8. The effect of formulation excipients on the penetration and lateral diffusion of ibuprofen on and within the stratum corneum following topical application to humans.
Gee CM; Watkinson AC; Nicolazzo JA; Finnin BC
J Pharm Sci; 2014 Mar; 103(3):909-19. PubMed ID: 24421242
[TBL] [Abstract][Full Text] [Related]
9. Emulsion-Based Intradermal Delivery of Melittin in Rats.
Han SM; Kim SG; Pak SC
Molecules; 2017 May; 22(5):. PubMed ID: 28534835
[TBL] [Abstract][Full Text] [Related]
10. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954
[TBL] [Abstract][Full Text] [Related]
11. Development and Optimization of Imiquimod-Loaded Nanostructured Lipid Carriers Using a Hybrid Design of Experiments Approach.
Kim S; Abdella S; Abid F; Afinjuomo F; Youssef SH; Holmes A; Song Y; Vaidya S; Garg S
Int J Nanomedicine; 2023; 18():1007-1029. PubMed ID: 36855538
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Skin Penetration Enhancer and Nanoemulsion Formulations Promote the Human Epidermal Permeation of Caffeine and Naproxen.
Abd E; Namjoshi S; Mohammed YH; Roberts MS; Grice JE
J Pharm Sci; 2016 Jan; 105(1):212-20. PubMed ID: 26554868
[TBL] [Abstract][Full Text] [Related]
13. Impact of different vehicles for laser-assisted drug permeation via skin: full-surface versus fractional ablation.
Lee WR; Shen SC; Aljuffali IA; Li YC; Fang JY
Pharm Res; 2014 Feb; 31(2):382-93. PubMed ID: 24022680
[TBL] [Abstract][Full Text] [Related]
14. Effect of tocopheryl polyethylene glycol succinate on the percutaneous penetration of minoxidil from water/ethanol/polyethylene glycol 400 solutions.
Sheu MT; Wu AB; Lin KP; Shen CH; Ho HO
Drug Dev Ind Pharm; 2006 Jun; 32(5):595-607. PubMed ID: 16720414
[TBL] [Abstract][Full Text] [Related]
15. Visualization, dermatopharmacokinetic analysis and monitoring the conformational effects of a microemulsion formulation in the skin stratum corneum.
Hathout RM; Mansour S; Geneidi AS; Mortada ND
J Colloid Interface Sci; 2011 Feb; 354(1):124-30. PubMed ID: 21067769
[TBL] [Abstract][Full Text] [Related]
16. Topical delivery of hexamidine.
Parisi N; Paz-Alvarez M; Matts PJ; Lever R; Hadgraft J; Lane ME
Int J Pharm; 2016 Jun; 506(1-2):332-9. PubMed ID: 27130367
[TBL] [Abstract][Full Text] [Related]
17. Nanoformulations for dermal delivery of imiquimod: The race of "soft" against "hard".
Petrová E; Chvíla S; Balouch M; Štěpánek F; Zbytovská J
Int J Pharm; 2023 Dec; 648():123577. PubMed ID: 37931726
[TBL] [Abstract][Full Text] [Related]
18. Improvement of Imiquimod Solubilization and Skin Retention via TPGS Micelles: Exploiting the Co-Solubilizing Effect of Oleic Acid.
Ghezzi M; Pescina S; Delledonne A; Ferraboschi I; Sissa C; Terenziani F; Remiro PFR; Santi P; Nicoli S
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575553
[TBL] [Abstract][Full Text] [Related]
19. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.
Pinheiro VA; Serikaku D; Baby AR; Velasco MV; Kaneko TM; Consiglieri VO
Pharm Dev Technol; 2015 Mar; 20(2):197-203. PubMed ID: 24286179
[TBL] [Abstract][Full Text] [Related]
20. Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action.
Yamane MA; Williams AC; Barry BW
J Pharm Pharmacol; 1995 Dec; 47(12A):978-89. PubMed ID: 8932680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
